Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Kolltan Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2088
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Kolltan Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Kolltan Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Kolltan Pharmaceuticals, Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Kolltan Pharmaceuticals, Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Kolltan Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Kolltan Pharmaceuticals, Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Kolltan Pharmaceuticals, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Kolltan Pharmaceuticals, Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Kolltan Pharmaceuticals, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 10
Partnership – Deal reports 10
CAPITAL RAISING 41
Capital Raising – Overview 41
Capital Raising – Deal reports 42
PRIVATE EQUITY & OWNERSHIP 57
Private Equity and Ownership – Overview 57
Private Equity and Ownership – Deal reports 58
APPENDIX 65
Contact Us 65
About MarketLine Financial Deals Database 65
Deal Definition and Methodology 67
About MarketLine 74

List of Tables
Table 1: Kolltan Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Table 2: Kolltan Pharmaceuticals M&A activity by geography (2014-YTD2018)
Table 3: Kolltan Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Table 4: Kolltan Pharmaceuticals capital raising by deal type (2014-YTD2018)
Table 5: Kolltan Pharmaceuticals private equity and ownership volume and value trend (2014-YTD2018)
Table 6: Kolltan Pharmaceuticals private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Kolltan Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Figure 2: Kolltan Pharmaceuticals M&A activity by geography (2014-YTD2018)
Figure 3: Kolltan Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Figure 4: Kolltan Pharmaceuticals capital raising by deal type (2014-YTD2018)
Figure 5: Kolltan Pharmaceuticals private equity and ownership volume and value trend (2014-YTD2018)
Figure 6: Kolltan Pharmaceuticals private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Kolltan Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dollar General Corporation:企業のM&A・事業提携・投資動向
    Dollar General Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dollar General Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • AdvanDx Inc-医療機器分野:企業M&A・提携分析
    Summary AdvanDx Inc (AdvanDx), a subsidiary of OpGen Inc is a healthcare solution provider that offers rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. The company operates molecular testing of positive blood cultures …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務情報
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mutual Trust Bank Limited:企業の戦略・SWOT・財務情報
    Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析
    Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • PTT Exploration and Production Public Co Ltd (PTTEP):石油・ガス:M&Aディール及び事業提携情報
    Summary PTT Exploration and Production Public Company Limited (PTTEP), a subsidiary of PTT Public Company Limited, is an oil and gas company. It carries out exploration, development and production of hydrocarbons. The company manages an array of exploration projects in different stages and producing …
  • Parexel International Corp:医療機器:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • Canadian Spirit Resources Inc (SPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Spirit Resources Inc (CSRI) is a natural resource provider that provides exploration and development services. The company offers exploration and production of natural gas in Montney Formation of Northeast British Columbia. It provides operation Farrell Creek area which is located a …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ImmunoGen Inc (IMGN):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …
  • Oasmia Pharmaceutical AB (OASM):企業の財務・戦略的SWOT分析
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops, manufactures, markets and sells drugs for human and veterinary oncology. The company’s pipeline for human health includes apealea (paclical), currently at registration and approval stage, for treating …
  • Avalign Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners, is a medical device company that supplies surgical implants, instruments, and delivery systems. The company offers precision machined instruments, cutting instruments, delivery systems, cases and trays, german sp …
  • Vascular Biogenics Ltd (VBLT):企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The company’s product pipeline includes VB-111. VBL’s product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for ca …
  • Neos Therapeutics Inc (NEOS):企業の財務・戦略的SWOT分析
    Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • JM AB:企業の戦略・SWOT・財務情報
    JM AB - Strategy, SWOT and Corporate Finance Report Summary JM AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Avista Corporation (AVA)-エネルギー分野:企業M&A・提携分析
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • Spicejet Limited:企業の戦略・SWOT・財務分析
    Spicejet Limited - Strategy, SWOT and Corporate Finance Report Summary Spicejet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Northern Trust Corporation:企業の戦略・SWOT・財務情報
    Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report Summary Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆